Database
Standardization for consistent, interoperable data inputs.
Why the platform exists, what its name means, and the philosophy that holds it together.
The challenge
As real-world data and real-world evidence become central to drug safety, treatment effectiveness, disease burden, post-marketing surveillance and reimbursement decisions, single-country or single-database studies increasingly fall short.
Countries differ in their healthcare systems, data structures, coding systems, population coverage, disease burden, prescribing habits and governance environments. Cross-national collaboration is therefore not only about increasing sample size — it is how we test whether findings are consistent, transportable and useful for decisions.
But collaboration runs into real obstacles: privacy constraints, inconsistent methods, incompatible data formats, difficulties in cross-border extrapolation, and the challenge of interpreting results that diverge between settings. Robust multinational evidence requires more than goodwill — it requires data, method and collaboration readiness built before any study begins.
The response
IMPRESIVE was created to make cross-national real-world evidence reproducible, comparable, transportable and decision-ready. It works as a federated network — built on common protocols, common data models, shared quality assurance and common analysis programs — so that data from different countries can answer the same question quickly, transparently and reproducibly, without ever moving raw individual-level records.
IMPRESIVE is not a one-off study. It is a platform that connects data preparedness, method preparedness, analysis preparedness and decision preparedness into one framework.
The goal is accelerated evidence generation and application. Harmonization is what makes it efficient, consistent and communicable.
Standardization for consistent, interoperable data inputs.
Reproducible, scalable execution of real-world studies.
Bridging the gap between evidence generation and decision-making.
The name
International Multi-database study PREparedness: Databases Standardization, Integration and Visualization for timely Evaluation on Disease and Treatment
Bringing together data from multiple countries and systems — different structures, populations and governance — under one research question.
The long-term capability to be ready: inventory, mapping, modules, quality checks, collaboration and governance — before a study begins.
The three technical foundations: a common language, a consistent analytic logic, and clear, comparable presentation of results.
The purpose: producing decision-grade real-world evidence in time to support clinical, regulatory, HTA, policy and industry decisions.
What makes it different
IMPRESIVE extends beyond a single study. It is the standing capability to run many — measured across four dimensions of readiness.
Whether the target population, exposures, outcomes, variables and data formats are adequate for the proposed study.
Whether the common protocol, analytical specifications and methods can be executed reproducibly — with variable definitions, code lists and QA programs in place.
Whether the respective responsibilities of the coordinating center and each data partner — local PIs, analysts, IRB / governance, result sharing and program revision — are defined and workable.
Whether result integration, visualization standards and the appropriate interpretation of cross-country heterogeneity are in place before findings are communicated.
The platform value
Core philosophy
IMPRESIVE is not about gathering data. It is about building a platform where different countries can use a common language, common methods and a common visualization framework to answer questions about disease and treatment — so that data is not merely compared, but jointly forms evidence that is more reliable, more transportable, and genuinely able to support decisions.
Prepared databases. Integrated evidence. Timely decisions.
Why multi-database studies →